Internal Medicine, Endocrinology, Diabetes, & Metabolism · Miami, FL
NPI
1356459630
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
8260 W Flagler St, Ste 1h
Miami, FL, 33144
Phone (305) 220-5191
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
294 services
Medicare patients, 2024
118
Average age 76
Drug cost, 2024
$1.4M
7,501 prescriptions
Company payments, 2025
$254
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos E Rivera was code 99214 (office e&m - established), 156 times for 97 patients. In total Carlos E Rivera billed 294 services in 4 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 156 | 97 | $100.70 | $16K |
| 36415 Venipuncture Blood Collection | Office | 112 | 73 | $8.65 | $969 |
| 99204 Office E&M - New | Office | 25 | 25 | $140.39 | $3,510 |
By year: 2022 $30K for 654 services; 2023 $26K for 393 services; 2024 $20K for 294 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 112 | 73 | $8.65 | $969 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos E Rivera prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 1,177 prescriptions and refills. In total Carlos E Rivera wrote 7,501 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 1,177 | 1,499 | 214 | $151K |
| Glipizide Generic | 500 | 813 | 118 | $2,036 |
| Levothyroxine Sodium Generic | 459 | 906 | 126 | $3,062 |
| Comfort Ez Pen Needle Pen Needle, Diabetic | 315 | 370 | 53 | $19K |
| Metformin Hcl Generic | 304 | 655 | 92 | $823 |
| Insulin Aspart Prot Mix 70-30 Insulin Aspart Prot/Insuln Asp | 286 | 335 | 52 | $39K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 242 | 388 | 77 | $15K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 224 | 321 | 48 | $51K |
| Januvia Sitagliptin Phosphate | 214 | 270 | 50 | $150K |
| Glipizide Er Glipizide | 204 | 299 | 40 | $917 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 181 | 256 | 33 | $34K |
| Ozempic Semaglutide | 175 | 201 | 33 | $190K |
| Glimepiride Generic | 159 | 375 | 48 | $901 |
| Synthroid Levothyroxine Sodium | 146 | 254 | 30 | $12K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 137 | 167 | 36 | $26K |
Brand drugs: 3,944 claims; generic drugs: 2,239 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos E Rivera $254 ($254 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $254.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 6 | $254 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.